67 research outputs found
Certain subclasses of multivalent functions defined by new multiplier transformations
In the present paper the new multiplier transformations
\mathrm{{\mathcal{J}% }}_{p}^{\delta }(\lambda ,\mu ,l) (\delta ,l\geq
0,\;\lambda \geq \mu \geq 0;\;p\in \mathrm{% }%\mathbb{N} )} of multivalent
functions is defined. Making use of the operator two new subclasses and \textbf{\ }of multivalent analytic
functions are introduced and investigated in the open unit disk. Some
interesting relations and characteristics such as inclusion relationships,
neighborhoods, partial sums, some applications of fractional calculus and
quasi-convolution properties of functions belonging to each of these subclasses
and
are
investigated. Relevant connections of the definitions and results presented in
this paper with those obtained in several earlier works on the subject are also
pointed out
Evidence for a backward peak in the gamma+d->pi^0+d cross section near the eta threshold
High-quality cross sections for the reaction gamma+d->pi^0+d have been
measured using the CLAS at Jefferson Lab over a wide energy range near and
above the eta-meson photoproduction threshold. At backward c.m. angles for the
outgoing pions, we observe a resonance-like structure near E_gamma=700 MeV. Our
model analysis shows that it can be explained by eta excitation in the
intermediate state. The effect is the result of the contribution of the
N(1535)S_11 resonance to the amplitudes of the subprocesses occurring between
the two nucleons and of a two-step process in which the excitation of an
intermediate eta meson dominates.Comment: slightly modified title, additional paragraph and a table (Table 2)
added on p. 5; to be submitted to EPJA, 6 pages, 3 figure
New insights into the genetic etiology of Alzheimer's disease and related dementias
Characterization of the genetic landscape of Alzheimer's disease (AD) and related dementias (ADD) provides a unique opportunity for a better understanding of the associated pathophysiological processes. We performed a two-stage genome-wide association study totaling 111,326 clinically diagnosed/'proxy' AD cases and 677,663 controls. We found 75 risk loci, of which 42 were new at the time of analysis. Pathway enrichment analyses confirmed the involvement of amyloid/tau pathways and highlighted microglia implication. Gene prioritization in the new loci identified 31 genes that were suggestive of new genetically associated processes, including the tumor necrosis factor alpha pathway through the linear ubiquitin chain assembly complex. We also built a new genetic risk score associated with the risk of future AD/dementia or progression from mild cognitive impairment to AD/dementia. The improvement in prediction led to a 1.6- to 1.9-fold increase in AD risk from the lowest to the highest decile, in addition to effects of age and the APOE ε4 allele
A pair of sub-Neptunes transiting the bright K-dwarf TOI-1064 characterized with CHEOPS
Stars and planetary system
SPECTROSCOPY OF HIGHLY-IONIZED HELIUM-LIKE AND LITHIUM-LIKE ATOMS
Recent precision spectroscopic measurements of 2s - 2p transition energies in high-Z helium-like and lithium-like ions are sensitive to relativistic and QED contributions. Comparisons are presented between the latest experimental results and theoretical calculations for these transitions along the helium-like and lithium-like isoelectronic sequences
Antipsychotics and cognitive decline in Alzheimer's disease: the LASER-Alzheimer's disease longitudinal study
Objective: To investigate in a longitudinal cohort of people with Alzheimer's disease whether taking antipsychotics is associated with more rapid cognitive deterioration. Method: From a sample of 224 people with Alzheimer's disease recruited as epidemiologically representative, those taking antipsychotic drugs for more than 6 months were compared with those who were not, in terms of change in three measures of cognition. The effects of potential mediators and confounders (demographic factors, neuropsychiatric symptoms, cognitive severity and cholinesterase inhibitors) were also examined. Results: No significant difference was observed in cognitive decline between those taking antipsychotics (atypical or any) and others on any measure of cognition. The only predictor of more cognitive decline was greater baseline cognitive severity (B = 3.3, 95% confidence interval 0.6 to 6.1, t = 2.4, p < 0.05). Although mortality was higher in those treated with antipsychotics, this reflected their greater age and severity of dementia. The results were the same when the whole cohort was included rather than the select group with potential to change who had been taking antipsychotics continuously. Conclusions: In this, the first cohort study investigating the effects of atypical antipsychotics on cognitive outcome in Alzheimer's disease, those taking antipsychotics were no more likely to decline cognitively over 6 months. Although clinicians should remain cautious when prescribing antipsychotic drugs to people with Alzheimer's disease, any increase in cognitive deterioration is not of the magnitude previously reported. There is a need for cohort studies that follow up patients from first prescription in clinical practice for a period of months rather than weeks to determine "real-life'' risks and benefits
Recommended from our members
Measurements of 2s-2p transition energies in helium-like and lithium-like nickel
The wavelength of the fine structure transition 1s2s /sup 3/S/sub 1/ - 1s2p /sup 3/P/sub 2/ in Ni XXVII has been measured using fast-ion spectroscopy. The transition energy is sensitive to relativistic and Lamb shift corrections in this high-Z two-electron system. Comparison is made with measurements in other high-Z ions and with recent theoretical calculations. A preliminary measurement of the 1s/sup 2/2s /sup 2/S/sub 1/2/ - 1s/sup 2/2p /sup 2/P/sub 1/2/ find structure transition in Ni XXVI is also reported. 18 refs., 1 fig., 2 tabs
- …